Study Shows Novel Flavoprotein Fluorescence Measure is Correlated with Age-Related Macular Degeneration (AMD) Stage

ANN ARBOR, Mich.--(BUSINESS WIRE)--OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced the publication of an Age-related Macular Degeneration (AMD) study in the Ophthalmic Surgery, Lasers and Imaging Retina journal. By quantifying the degree of retinal oxidative stress and mitochondrial dysfunction, these findings suggest that the novel FPF measure can categorize AMD patients by stage, which may better